Healthcare

Assisted Reproductive Technology Market Size Analysis 2022 To 2030

The global assisted reproductive technology market size accounted for US$ 26.3 Bn in 2021 and is projected to reach around USD 53.1 7 Bn by 2030, growing at a CAGR of 8.12% from 2022 to 2030.

Assisted Reproductive Technology Market Size 2022 To 2030

Report Summary

The global assisted reproductive technology market report provides a Point-by-Point and In-Depth analysis of global market size, regional and country-level market size, market share, segmentation market growth, competitive landscape, sales analysis, opportunities analysis, strategic market growth analysis, the impact of domestic and global market key players, value chain optimization, trade regulations, recent developments, product launches, area marketplace expanding, and technological innovations.

The study offers a comprehensive analysis on diverse features, including production capacities, demand, product developments, revenue generation, and sales in the assisted reproductive technology market across the globe.

A comprehensive estimate on the assisted reproductive technology market has been provided through an optimistic scenario as well as a conservative scenario, taking into account the sales of assisted reproductive technology during the forecast period. Price point comparison by region with global average price is also considered in the study.

Download Access to a Free Copy of Our Latest Sample Report@ https://www.precedenceresearch.com/sample/2339

Assisted Reproductive Technology Market Scope 

Report Coverage Details
Market Size in 2022 USD 28.44 Billion
Market Size by 2030 USD 53.1 Billion
Growth Rate from 2022 to 2030 CAGR of 8.12%
Base Year 2021
Forecast Period 2022 to 2030
Segments Covered
  • By Product
  • By Technology
  • By Diagnosis
  • By End-User

Key Highlights:

Reports Coverage: It incorporates key market sections, key makers secured, the extent of items offered in the years considered, worldwide containerized assisted reproductive technology market and study goals. Moreover, it contacts the division study gave in the report based on the sort of item and applications.

Market Outline: This area stresses the key investigations, market development rate, serious scene, market drivers, patterns, and issues notwithstanding the naturally visible pointers.

Market Production by Region: The report conveys information identified with import and fare, income, creation, and key players of every single local market contemplated are canvassed right now.

Also Read: Single-use Bioreactors Market Size Analysis 2022 To 2030

Assisted Reproductive Technology Market Players

The report includes the profiles of key assisted reproductive technology market companies along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information, key development in past five years.

Major companies operating in this area 

  • Vitrolife AB
  • Thermo Fisher Scientific, Inc
  • The Cooper Companies, Inc (Cooper Surgical Inc.)
  • Progyny Inc.
  • Oxford Gene Technology
  • Millendo Therapeutics, Inc
  • Merck KGaA (EMD Serono, Inc)
  • Genera Biomedx
  • Fujifilm Holdings Corporation (Irvine Scientific Sales Company)
  • Cook Medical Inc
  • Ferring B.V.
  • Bloom IVF Centre
  • European Sperm Bank
  • Microm U.K. Ltd
  • Cosmos Biomedical Ltd
  • Cryolab Ltd

Market Segmentation

By Product

  • Instrument
    • Laser systems
    • Micromanipulator
    • Cabinet
    • Ovum aspiration pump
    • Imaging systems
    • Incubator
    • Cryosystem
    • Sperm separation system
    • Others
  • Accessory & Disposable
  • Reagents & media
    • Embryo culture media
    • Ovum processing media
    • Semen processing media
    • Cryopreservation media

By Technology

  • In-Vitro Fertilization (IVF)
    • Fresh Donor
    • Frozen Donor
    • Fresh Non-Donor
    • Frozen Non-Donor
  • Artificial Insemination
    • Intrauterine Insemination
    • Intracervical Insemination
    • Intravaginal Insemination
    • Intratubal Insemination

By Diagnosis

  • Ovulation Testing
  • Hysterosalpingography

By End-User 

  • Ambulatory surgical centers
  • Hospitals
  • Clinics
  • Diagnostic centers
  • Gynecology Centers
  • Feminist Health Centers
  • IVF Centers

Regional Segmentation

  • North America (U.S., Canada, Mexico)
  • Europe (Germany, France, U.K., Italy, Spain, Rest of Europe)
  • Asia-Pacific (China, Japan, India, Southeast Asia and Rest of APAC)
  • Latin America (Brazil and Rest of Latin America)
  • Middle East and Africa (GCC, North Africa, South Africa, Rest of MEA)

Research Methodology

Secondary Research

It involves company databases such as Hoover’s: This assists us to recognize financial information, the structure of the market participants and industry’s competitive landscape.

The secondary research sources referred in the process are as follows:

  • Governmental bodies, and organizations creating economic policies
  • National and international social welfare institutions
  • Company websites, financial reports and SEC filings, broker and investor reports
  • Related patent and regulatory databases
  • Statistical databases and market reports
  • Corporate Presentations, news, press release, and specification sheet of Manufacturers

Primary Research

Primary research includes face-to-face interviews, online surveys, and telephonic interviews.

  • Means of primary research: Email interactions, telephonic discussions and Questionnaire-based research etc.
  • In order to validate our research findings and analysis, we conduct primary interviews of key industry participants. Insights from primary respondents help in validating the secondary research findings. It also develops Research Team’s expertise and market understanding.

TABLE OF CONTENT

Chapter 1. Introduction

1.1. Research Objective

1.2. Scope of the Study

1.3. Definition

Chapter 2. Research Methodology

2.1. Research Approach

2.2. Data Sources

2.3. Assumptions & Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Market Variables and Scope 

4.1. Introduction

4.2. Market Classification and Scope

4.3. Industry Value Chain Analysis

4.3.1. Raw Material Procurement Analysis

4.3.2. Sales and Distribution Channel Analysis

4.3.3. Downstream Buyer Analysis

Chapter 5. COVID 19 Impact on Assisted Reproductive Technology Market 

5.1. COVID-19 Landscape: Assisted Reproductive Technology Industry Impact

5.2. COVID 19 – Impact Assessment for the Industry

5.3. COVID 19 Impact: Global Major Government Policy

5.4. Market Trends and Opportunities in the COVID-19 Landscape

Chapter 6. Market Dynamics Analysis and Trends

6.1. Market Dynamics

6.1.1. Market Drivers

6.1.2. Market Restraints

6.1.3. Market Opportunities

6.2. Porter’s Five Forces Analysis

6.2.1. Bargaining power of suppliers

6.2.2. Bargaining power of buyers

6.2.3. Threat of substitute

6.2.4. Threat of new entrants

6.2.5. Degree of competition

Chapter 7. Competitive Landscape

7.1.1. Company Market Share/Positioning Analysis

7.1.2. Key Strategies Adopted by Players

7.1.3. Vendor Landscape

7.1.3.1. List of Suppliers

7.1.3.2. List of Buyers

Chapter 8. Global Assisted Reproductive Technology Market, By Product

8.1. Assisted Reproductive Technology Market, by Product, 2022-2030

8.1.1. Instrument

8.1.1.1. Market Revenue and Forecast (2017-2030)

8.1.2. Accessory & Disposable

8.1.2.1. Market Revenue and Forecast (2017-2030)

8.1.3. Reagents & media

8.1.3.1. Market Revenue and Forecast (2017-2030)

Chapter 9. Global Assisted Reproductive Technology Market, By Technology

9.1. Assisted Reproductive Technology Market, by Technology, 2022-2030

9.1.1. In-Vitro Fertilization (IVF)

9.1.1.1. Market Revenue and Forecast (2017-2030)

9.1.2. Artificial Insemination

9.1.2.1. Market Revenue and Forecast (2017-2030)

Chapter 10. Global Assisted Reproductive Technology Market, By Diagnosis 

10.1. Assisted Reproductive Technology Market, by Diagnosis, 2022-2030

10.1.1. Ovulation Testing

10.1.1.1. Market Revenue and Forecast (2017-2030)

10.1.2. Hysterosalpingography

10.1.2.1. Market Revenue and Forecast (2017-2030)

Chapter 11. Global Assisted Reproductive Technology Market, By End-User 

11.1. Assisted Reproductive Technology Market, by End-User, 2022-2030

11.1.1. Ambulatory surgical centers

11.1.1.1. Market Revenue and Forecast (2017-2030)

11.1.2. Hospitals

11.1.2.1. Market Revenue and Forecast (2017-2030)

11.1.3. Clinics

11.1.3.1. Market Revenue and Forecast (2017-2030)

11.1.4. Diagnostic centers

11.1.4.1. Market Revenue and Forecast (2017-2030)

11.1.5. Gynecology Centers

11.1.5.1. Market Revenue and Forecast (2017-2030)

11.1.6. Feminist Health Centers

11.1.6.1. Market Revenue and Forecast (2017-2030)

11.1.7. IVF Centers

11.1.7.1. Market Revenue and Forecast (2017-2030)

Chapter 12. Global Assisted Reproductive Technology Market, Regional Estimates and Trend Forecast

12.1. North America

12.1.1. Market Revenue and Forecast, by Product (2017-2030)

12.1.2. Market Revenue and Forecast, by Technology (2017-2030)

12.1.3. Market Revenue and Forecast, by Diagnosis (2017-2030)

12.1.4. Market Revenue and Forecast, by End-User (2017-2030)

12.1.5. U.S.

12.1.5.1. Market Revenue and Forecast, by Product (2017-2030)

12.1.5.2. Market Revenue and Forecast, by Technology (2017-2030)

12.1.5.3. Market Revenue and Forecast, by Diagnosis (2017-2030)

12.1.5.4. Market Revenue and Forecast, by End-User (2017-2030)

12.1.6. Rest of North America

12.1.6.1. Market Revenue and Forecast, by Product (2017-2030)

12.1.6.2. Market Revenue and Forecast, by Technology (2017-2030)

12.1.6.3. Market Revenue and Forecast, by Diagnosis (2017-2030)

12.1.6.4. Market Revenue and Forecast, by End-User (2017-2030)

12.2. Europe

12.2.1. Market Revenue and Forecast, by Product (2017-2030)

12.2.2. Market Revenue and Forecast, by Technology (2017-2030)

12.2.3. Market Revenue and Forecast, by Diagnosis (2017-2030)

12.2.4. Market Revenue and Forecast, by End-User (2017-2030)

12.2.5. UK

12.2.5.1. Market Revenue and Forecast, by Product (2017-2030)

12.2.5.2. Market Revenue and Forecast, by Technology (2017-2030)

12.2.5.3. Market Revenue and Forecast, by Diagnosis (2017-2030)

12.2.5.4. Market Revenue and Forecast, by End-User (2017-2030)

12.2.6. Germany

12.2.6.1. Market Revenue and Forecast, by Product (2017-2030)

12.2.6.2. Market Revenue and Forecast, by Technology (2017-2030)

12.2.6.3. Market Revenue and Forecast, by Diagnosis (2017-2030)

12.2.6.4. Market Revenue and Forecast, by End-User (2017-2030)

12.2.7. France

12.2.7.1. Market Revenue and Forecast, by Product (2017-2030)

12.2.7.2. Market Revenue and Forecast, by Technology (2017-2030)

12.2.7.3. Market Revenue and Forecast, by Diagnosis (2017-2030)

12.2.7.4. Market Revenue and Forecast, by End-User (2017-2030)

12.2.8. Rest of Europe

12.2.8.1. Market Revenue and Forecast, by Product (2017-2030)

12.2.8.2. Market Revenue and Forecast, by Technology (2017-2030)

12.2.8.3. Market Revenue and Forecast, by Diagnosis (2017-2030)

12.2.8.4. Market Revenue and Forecast, by End-User (2017-2030)

12.3. APAC

12.3.1. Market Revenue and Forecast, by Product (2017-2030)

12.3.2. Market Revenue and Forecast, by Technology (2017-2030)

12.3.3. Market Revenue and Forecast, by Diagnosis (2017-2030)

12.3.4. Market Revenue and Forecast, by End-User (2017-2030)

12.3.5. India

12.3.5.1. Market Revenue and Forecast, by Product (2017-2030)

12.3.5.2. Market Revenue and Forecast, by Technology (2017-2030)

12.3.5.3. Market Revenue and Forecast, by Diagnosis (2017-2030)

12.3.5.4. Market Revenue and Forecast, by End-User (2017-2030)

12.3.6. China

12.3.6.1. Market Revenue and Forecast, by Product (2017-2030)

12.3.6.2. Market Revenue and Forecast, by Technology (2017-2030)

12.3.6.3. Market Revenue and Forecast, by Diagnosis (2017-2030)

12.3.6.4. Market Revenue and Forecast, by End-User (2017-2030)

12.3.7. Japan

12.3.7.1. Market Revenue and Forecast, by Product (2017-2030)

12.3.7.2. Market Revenue and Forecast, by Technology (2017-2030)

12.3.7.3. Market Revenue and Forecast, by Diagnosis (2017-2030)

12.3.7.4. Market Revenue and Forecast, by End-User (2017-2030)

12.3.8. Rest of APAC

12.3.8.1. Market Revenue and Forecast, by Product (2017-2030)

12.3.8.2. Market Revenue and Forecast, by Technology (2017-2030)

12.3.8.3. Market Revenue and Forecast, by Diagnosis (2017-2030)

12.3.8.4. Market Revenue and Forecast, by End-User (2017-2030)

12.4. MEA

12.4.1. Market Revenue and Forecast, by Product (2017-2030)

12.4.2. Market Revenue and Forecast, by Technology (2017-2030)

12.4.3. Market Revenue and Forecast, by Diagnosis (2017-2030)

12.4.4. Market Revenue and Forecast, by End-User (2017-2030)

12.4.5. GCC

12.4.5.1. Market Revenue and Forecast, by Product (2017-2030)

12.4.5.2. Market Revenue and Forecast, by Technology (2017-2030)

12.4.5.3. Market Revenue and Forecast, by Diagnosis (2017-2030)

12.4.5.4. Market Revenue and Forecast, by End-User (2017-2030)

12.4.6. North Africa

12.4.6.1. Market Revenue and Forecast, by Product (2017-2030)

12.4.6.2. Market Revenue and Forecast, by Technology (2017-2030)

12.4.6.3. Market Revenue and Forecast, by Diagnosis (2017-2030)

12.4.6.4. Market Revenue and Forecast, by End-User (2017-2030)

12.4.7. South Africa

12.4.7.1. Market Revenue and Forecast, by Product (2017-2030)

12.4.7.2. Market Revenue and Forecast, by Technology (2017-2030)

12.4.7.3. Market Revenue and Forecast, by Diagnosis (2017-2030)

12.4.7.4. Market Revenue and Forecast, by End-User (2017-2030)

12.4.8. Rest of MEA

12.4.8.1. Market Revenue and Forecast, by Product (2017-2030)

12.4.8.2. Market Revenue and Forecast, by Technology (2017-2030)

12.4.8.3. Market Revenue and Forecast, by Diagnosis (2017-2030)

12.4.8.4. Market Revenue and Forecast, by End-User (2017-2030)

12.5. Latin America

12.5.1. Market Revenue and Forecast, by Product (2017-2030)

12.5.2. Market Revenue and Forecast, by Technology (2017-2030)

12.5.3. Market Revenue and Forecast, by Diagnosis (2017-2030)

12.5.4. Market Revenue and Forecast, by End-User (2017-2030)

12.5.5. Brazil

12.5.5.1. Market Revenue and Forecast, by Product (2017-2030)

12.5.5.2. Market Revenue and Forecast, by Technology (2017-2030)

12.5.5.3. Market Revenue and Forecast, by Diagnosis (2017-2030)

12.5.5.4. Market Revenue and Forecast, by End-User (2017-2030)

12.5.6. Rest of LATAM

12.5.6.1. Market Revenue and Forecast, by Product (2017-2030)

12.5.6.2. Market Revenue and Forecast, by Technology (2017-2030)

12.5.6.3. Market Revenue and Forecast, by Diagnosis (2017-2030)

12.5.6.4. Market Revenue and Forecast, by End-User (2017-2030)

Chapter 13. Company Profiles

13.1. Vitrolife AB

13.1.1. Company Overview

13.1.2. Product Offerings

13.1.3. Financial Performance

13.1.4. Recent Initiatives

13.2. Thermo Fisher Scientific, Inc

13.2.1. Company Overview

13.2.2. Product Offerings

13.2.3. Financial Performance

13.2.4. Recent Initiatives

13.3. The Cooper Companies, Inc (Cooper Surgical Inc.)

13.3.1. Company Overview

13.3.2. Product Offerings

13.3.3. Financial Performance

13.3.4. Recent Initiatives

13.4. Progyny Inc.

13.4.1. Company Overview

13.4.2. Product Offerings

13.4.3. Financial Performance

13.4.4. Recent Initiatives

13.5. Oxford Gene Technology

13.5.1. Company Overview

13.5.2. Product Offerings

13.5.3. Financial Performance

13.5.4. Recent Initiatives

13.6. Millendo Therapeutics, Inc

13.6.1. Company Overview

13.6.2. Product Offerings

13.6.3. Financial Performance

13.6.4. Recent Initiatives

13.7. Merck KGaA (EMD Serono, Inc)

13.7.1. Company Overview

13.7.2. Product Offerings

13.7.3. Financial Performance

13.7.4. Recent Initiatives

13.8. Genera Biomedx

13.8.1. Company Overview

13.8.2. Product Offerings

13.8.3. Financial Performance

13.8.4. Recent Initiatives

13.9. Fujifilm Holdings Corporation (Irvine Scientific Sales Company)

13.9.1. Company Overview

13.9.2. Product Offerings

13.9.3. Financial Performance

13.9.4. Recent Initiatives

13.10. Cook Medical Inc

13.10.1. Company Overview

13.10.2. Product Offerings

13.10.3. Financial Performance

13.10.4. Recent Initiatives

Chapter 14. Research Methodology

14.1. Primary Research

14.2. Secondary Research

14.3. Assumptions

Chapter 15. Appendix

15.1. About Us

15.2. Glossary of Terms

Thanks for reading you can also get individual chapter-wise sections or region-wise report versions such as North America, Europe, or the Asia Pacific.

Contact Us:

Mr. Alex

Sales Manager

Call: +1 9197 992 333

Emailsales@precedenceresearch.com

Web: https://www.precedenceresearch.com

Show More

Related Articles

Back to top button